Solamargine, in this research, caused epigenetic changes and could be a novel strategy to inhibit lung cancer cell growth via precisely targeting EP4 downstream c-Jun through ERK1/2-mediated a decrease in DNMT1. This evidence concerns the gene MAPK3 and lung carcinoma.